ADMA Biologics Financial Overview
ADMA Biologics's market cap is currently $4.66B. The company's EPS TTM is $0.16; its P/E ratio is 22.99; ADMA Biologics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $0.18. See an overview of income statement, balance sheet, and cash flow financials.
